HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shunsei Hirohata Selected Research

Central Nervous System Lupus Vasculitis

1/2021Role of Serum IL-6 in Neuropsychiatric Systemic lupus Erythematosus.
1/2019Differential expression of antibodies to NMDA receptor in anti-NMDA receptor encephalitis and in neuropsychiatric systemic lupus erythematosus.
11/2018Role of serum autoantibodies in blood brain barrier damages in neuropsychiatric systemic lupus erythematosus.
1/2018Understanding the Antibody Repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorder: Do They Share Common Targets?
1/2018Elevation of serum anti-glucose-regulated protein 78 antibodies in neuropsychiatric systemic lupus erythematosus.
1/2017Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus.
1/2016Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus.
4/2008Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus.
1/2006Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shunsei Hirohata Research Topics

Disease

18Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2022 - 09/2003
16Rheumatoid Arthritis
11/2022 - 04/2002
9Psychotic Disorders (Schizoaffective Disorder)
01/2021 - 03/2005
9Central Nervous System Lupus Vasculitis
01/2021 - 01/2006
4Atrophy
05/2021 - 06/2012
4Cognitive Dysfunction
04/2021 - 03/2014
4Confusion (Bewilderment)
01/2021 - 10/2014
4Mood Disorders (Mood Disorder)
01/2021 - 01/2006
4Osteoarthritis
11/2007 - 06/2002
3Arthritis (Polyarthritis)
10/2022 - 11/2007
3Inflammation (Inflammations)
01/2022 - 02/2013
3Anxiety Disorders (Anxiety Disorder)
01/2021 - 03/2014
3Systemic Scleroderma (Systemic Sclerosis)
11/2020 - 04/2012
3Behcet Syndrome (Behcet's Syndrome)
06/2016 - 10/2007
3Autoimmune Diseases (Autoimmune Disease)
01/2016 - 05/2005
3Hepatitis
11/2014 - 03/2005
2Neoplasms (Cancer)
01/2016 - 09/2009
2Lupus Nephritis
11/2014 - 08/2011
2Vasculitis (Vasculitides)
02/2014 - 06/2004
2Meningitis
02/2014 - 06/2004
2Osteoporosis
11/2013 - 09/2003
2Ataxia (Dyssynergia)
11/2013 - 06/2004
2Dysarthria (Spastic Dysarthria)
11/2013 - 06/2004
2Dementia (Dementias)
11/2013 - 06/2004
2Connective Tissue Diseases (Connective Tissue Disease)
04/2012 - 05/2008
2Myositis (Idiopathic Inflammatory Myopathies)
03/2012 - 09/2011
2Meningoencephalitis
11/2009 - 06/2004
2Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
02/2009 - 05/2008
2Neurologic Manifestations (Neurological Manifestations)
09/2008 - 01/2007
1Necrosis
11/2022
1Pulmonary Embolism
09/2022
1Hyperferritinemia
01/2022
1Disease Progression
10/2020
1Anti-N-Methyl-D-Aspartate Receptor Encephalitis
01/2019
1Autoimmune Diseases of the Nervous System
01/2019
1Neuromyelitis Optica (Devic's Disease)
01/2018
1Demyelinating Diseases (Demyelinating Disease)
01/2018
1Encephalitis (Encephalitis, Rasmussen)
11/2016
1Pulmonary Hypertension
11/2016
1Ulcer
06/2016
1Cicatrix (Scar)
06/2016
1Otitis Media
02/2014
1Sinusitis
02/2014
1Mastoiditis
02/2014
1Headache Disorders (Headache Syndromes)
02/2014
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
02/2014
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
02/2014

Drug/Important Bio-Agent (IBA)

16AntibodiesIBA
04/2021 - 01/2004
11Interleukin-6 (Interleukin 6)IBA
01/2022 - 06/2004
11AutoantibodiesIBA
01/2022 - 01/2004
9Proteins (Proteins, Gene)FDA Link
03/2018 - 03/2005
7Adrenal Cortex Hormones (Corticosteroids)IBA
10/2020 - 01/2003
5N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2019 - 04/2008
4Messenger RNA (mRNA)IBA
11/2022 - 01/2006
4Anti-ribosomal P protein autoantibodiesIBA
01/2022 - 03/2005
4Immunoglobulin G (IgG)IBA
01/2018 - 06/2002
3Prednisolone (Predate)FDA LinkGeneric
10/2022 - 02/2014
3Biomarkers (Surrogate Marker)IBA
06/2022 - 04/2021
3Chemokine CX3CL1IBA
03/2012 - 06/2005
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2009 - 01/2003
2AlbuminsIBA
11/2018 - 03/2014
2Tumor Necrosis Factor InhibitorsIBA
09/2017 - 10/2013
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2016 - 02/2014
2Infliximab (Remicade)FDA Link
06/2016 - 10/2013
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2016 - 01/2014
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
02/2014 - 06/2004
2GlucocorticoidsIBA
11/2013 - 05/2005
2Glutamate Receptors (Glutamate Receptor)IBA
02/2013 - 04/2008
2ChemokinesIBA
03/2012 - 06/2005
2Pharmaceutical PreparationsIBA
01/2012 - 01/2003
2Methotrexate (Mexate)FDA LinkGeneric
09/2009 - 01/2009
2Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
02/2009 - 05/2008
2bucillamine (SA 96)IBA
01/2009 - 01/2004
1Phosphotransferases (Kinase)IBA
11/2022
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2022
1SteroidsIBA
10/2022
1AnticoagulantsIBA
09/2022
1Ferritins (Ferritin)IBA
01/2022
1poly(dG-dA)n.poly(dC-dT)n (((GA)n))IBA
11/2020
1Protein-Arginine Deiminase Type 2IBA
03/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1Myelin-Oligodendrocyte GlycoproteinIBA
01/2018
1Aquaporin 4IBA
01/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1tocilizumab (atlizumab)FDA Link
09/2017
1Complement C3 (C3 Complement)IBA
01/2017
1Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA
01/2017
1Abatacept (Orencia)FDA Link
01/2017
1C-Reactive ProteinIBA
06/2016
1Protein Isoforms (Isoforms)IBA
01/2016
1NR1 NMDA receptorIBA
01/2016
1EpitopesIBA
01/2016
1N-Methylaspartate (NMDA)IBA
01/2016
13' Untranslated Regions (3' UTR)IBA
01/2016
1HLA-G Antigens (HLA G)IBA
01/2016
1CPNBDIBA
02/2015
1Peroxidase (Myeloperoxidase)IBA
02/2014
1Peptide Hydrolases (Proteases)FDA Link
02/2014
1Myeloblastin (Proteinase 3)IBA
02/2014

Therapy/Procedure

9Therapeutics
11/2016 - 01/2003